Variables | Categories | Censored n (%) | IRC (event) n (%) | CHR (95%CI) | AHR (95%CI) | P-value |
---|---|---|---|---|---|---|
Sex | Male | 70(28.57) | 175(71.43) | 1.14(.92,1.43) | 1.28(1.02, 1.60) | .03 |
Female | 74(34.58) | 140(65.42) | 1 | 1 | . | |
Functional status | No limitation | 121(31.84) | 259(68.16) | 1 | 1 | . |
Moderate or severe limitation | 23(29.11) | 56(70.89) | 1.31(.98,1.75) | 1.30(.97, 1.74) | .079 | |
History tuberculosis | Yes | 11(21.15) | 41(78.85) | 1.46(1.05, 2.03) | 1.59(1.14,2.23) | .007 |
No | 133(32.68) | 274(67.32) | 1 | 1 | . | |
WHO clinical stage deterioration | Yes | 2(25.00) | 6(75.00) | 1.78(.79,4.00) | 1.69(.74, 3.83) | .210 |
No | 142(31.49) | 309(68.51) | 1 | 1 | . | |
Adherence | Good | 129(36.54) | 224(63.46) | 1 | 1 | . |
Poor/fair | 15(14.15) | 91(85.85) | 1.52(1.2,1.95) | 1.49 (1.16, 1.92) | .002 | |
ART drug regimen | NVP based | 62 (24.41) | 192(75.59) | 1.32(1.05,1.66) | 1.45(1.15, 1.84) | .002 |
EFV based | 55 (31.61) | 119(68.39) | 1 | 1 | . | |
DTG based | 5 (83.33) | 1(16.67) | .99(.14,7.2) | .34(.05, 2.54) | .296 | |
LPVr based | 22(88.00) | 3(12.00) | .38(.12, 1.12) | .22(.07, .70) | .011 |